FDA panel recommends Pfizer’s low-dose Covid vaccine for kids ages 5 to 11
Published Tue, Oct 26 20214:17 PM EDTUpdated Wed, Oct 27 202111:42 AM EDT

Key Points

* A key FDA advisory committee on Tuesday recommended a lower dose of Pfizer and BioNTech’s Covid-19 vaccine for children ages 5 to 11.
* The vote was nearly unanimous with 17 members backing it and one abstention.
* The endorsement was a critical step in getting some 28 million more kids in the U.S. protected against the virus as the delta variant spreads.
* The agency doesn’t always follow the advice of its independent committee, but it often does.

https://www.cnbc.com/2021/10/26/fda-panel-recommends-pfizers-low-dose-covid-vaccine-for-kids-ages-5-to-11.html